Humana Inc. (HUM): Price and Financial Metrics
HUM Stock Summary
- With a market capitalization of $53,247,037,682, Humana Inc has a greater market value than 95.47% of US stocks.
- Humana Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 93.49% of US listed stocks.
- In terms of volatility of its share price, HUM is more volatile than only 1.52% of stocks we're observing.
- Stocks that are quantitatively similar to HUM, based on their financial statements, market capitalization, and price volatility, are PGR, DG, EMR, WBA, and JCI.
- Visit HUM's SEC page to see the company's official filings. To visit the company's web site, go to www.humana.com.
HUM Stock Price Chart Interactive Chart >
HUM Price/Volume Stats
| Current price | $422.75 | 52-week high | $474.70 |
| Prev. close | $417.11 | 52-week low | $344.95 |
| Day low | $417.30 | Volume | 640,100 |
| Day high | $424.74 | Avg. volume | 1,074,234 |
| 50-day MA | $397.45 | Dividend yield | 0.67% |
| 200-day MA | $405.96 | Market Cap | 54.54B |
Humana Inc. (HUM) Company Bio
Humana operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The company was founded in 1964 and is based in Louisville, Kentucky.
HUM Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $422.75 | $10264.48 | 2384% |
Below please find a table outlining a discounted cash flow forecast for HUM, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Humana Inc ranked in the 94th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Humana Inc, consider:
- In the past 5.56 years, Humana Inc has a compound free cash flow growth rate of 1.1%; that's higher than 85.65% of free cash flow generating stocks in the Healthcare sector.
- HUM's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 29.33% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 2335% |
| 1% | 2360% |
| 2% | 2384% |
| 3% | 2408% |
| 4% | 2433% |
| 5% | 2457% |
Want more companies with a valuation profile/forecast similar to that of Humana Inc? See PCYN, AMRX, GRFS, MNKKQ, and AKU.
Latest HUM News From Around the Web
Below are the latest news stories about Humana Inc that investors may wish to consider to help them evaluate HUM as an investment opportunity.
Humana (HUM) to Support Eligible Medicaid Members in OhioHumana (HUM) to improve health outcomes of Medicaid members in Ohio through contract wins. |
Is Humana Inc. (HUM) A Smart Long-Term Buy?Oakmark Funds, an investment management firm, published its “Oakmark Equity and Income Fund” first quarter 2021 investor letter – a copy of which can be seen here. A return of 10.3% was reported by the fund for the Q1 of 2021, outperforming its Lipper Balanced Fund benchmark that delivered a 5.4% return for the same […] |
Goldman Sach leveraged finance veteran jumps ship to health insurer Humana's corporate M&A teamSummary List Placement A near 20-year veteran of Goldman Sachs capital markets team has jumped ship to health insurer Humana. Logan Nicholson, who led Goldman's US leveraged finance capital markets unit, will lead corporate development and mergers and acquisitions team at Humana, according to a source familiar with the move. Goldman, meanwhile, has poached Chris Bonner from rival bank JP Morgan to replace Nicholson, a spokesperson for Goldman confirmed. Reuters first reported on Bonner's move on Tuesday. Bonner, who was JP Morgan's co-head of leveraged finance capital markets, will report to Kevin Sterling, Goldman's head of leveraged finance for the Americas. Sterling reports to Christina Minnis, Goldman's co-head of global credit finance. A spokesperson for JP Morgan declined to comme... |
Humana Commits $1.5 Million to Boys & Girls Clubs of America to Address Food Insecurity and Drive Healthy Habits For Millions of Youth Across USHumana Commits $1.5 Million to Boys & Girls Clubs of America to Address Food Insecurity and Drive Healthy Habits For Millions of Youth Across US |
Humana Healthy Horizons Partners with GoNoodle® to Boost Physical and Mental Health for 2.4 Million KidsHumana Healthy Horizons partners with GoNoodle to boost physical and mental health for 2.4 million kids. |
HUM Price Returns
| 1-mo | 5.04% |
| 3-mo | 4.09% |
| 6-mo | -3.11% |
| 1-year | 20.35% |
| 3-year | 48.44% |
| 5-year | 156.82% |
| YTD | 3.21% |
| 2020 | 12.71% |
| 2019 | 28.94% |
| 2018 | 15.89% |
| 2017 | 22.60% |
| 2016 | 14.85% |
HUM Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching HUM
Want to do more research on Humana Inc's stock and its price? Try the links below:Humana Inc (HUM) Stock Price | Nasdaq
Humana Inc (HUM) Stock Quote, History and News - Yahoo Finance
Humana Inc (HUM) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...